Retatrutide 5mg

Important note: Retatrutide is not yet FDA-approved and remains in Phase 3 clinical trials. It is only available in research studies. Consult a healthcare provider for the latest information, as individual results vary. Retatrutide represents a promising next-generation option for obesity, type 2 diabetes, and related metabolic conditions by addressing appetite, digestion, insulin dynamics, and energy use in one therapy.